| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.17 | 0.0001 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.089 | 0.03 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.089 | 0.05 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.081 | 0.06 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.06 | 0.2 |